Foukakis T

AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial.

Salim M, Liu Y, Sorkhei M, ..., Smith K, Strand F

Nat. Med. 30 (9) 2623-2630 [2024-09-00; online 2024-07-08]

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.

Wang K, Zerdes I, Johansson HJ, ..., Matikas A, Foukakis T

Nat Commun 15 (1) 3837 [2024-05-07; online 2024-05-07]

Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.

Chen X, Sifakis EG, Robertson S, ..., Ma R, Hartman J

Proc. Natl. Acad. Sci. U.S.A. 120 (1) e2209856120 [2023-01-03; online 2022-12-27]

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study.

Zerdes I, Simonetti M, Matikas A, ..., Crosetto N, Foukakis T

NPJ Breast Cancer 7 (1) 144 [2021-11-19; online 2021-11-19]